COVID-19
TOOLBOX
Filter
57
Featured
Language
Document type
Resource Platforms
35
Studies & Reports
7
Situation Updates
5
Online Courses
3
Fact sheets
3
No document type
2
Training Material
1
Guidelines
1
Countries / Regions
Germany
3
Russia
3
South Africa
2
China
1
Africa
1
Western and Central Europe
1
United Kingdom
1
Brazil
1
Authors & Publishers
Cochrane Library
4
B.S. Kamps
3
et al.
3
Hoffmann, C.
3
World Health Organization WHO
3
BMJ
2
British Medical Journal
2
Kamps, B.S.
2
Pan American Health Organisation PAHO
2
The New England Journal of Medicine
2
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
Allen Institute for AI
1
American Medical Association
1
and C. Hoffmann
1
Bundesinstitut für Arzneimittel und Medizinprodukte
1
C. Hoffmann, et al.
1
Centers for Disease Control and Prevention CDC
1
Clincial Care Options
1
Clinical Care Options
1
CNRS
1
Cochrane Iberoámerica
1
Cochrane Library (Trusted evidence. Informed decisions. Better health.)
1
Cold Spring Harbor Laboratory
1
COVID-19 Comprehensive Resource Center
1
COVID-End Evidence Network to support Decision-making
1
Deutsche Gesellschaft für Public Health et al.
1
European Medicines Agency EMA
1
Evidence Aid
1
Federal Ministry of Education and Research, Germany
1
FIND
1
Foundation for Innovative and New Diagnostics
1
Global Innovation Exchange
1
Google Scholar
1
JAMA Network
1
Kamradt, T., and B.S. Kamps
1
Kamradt, T., B.S. Kamps J. García-Rosales Delgado
1
London School of Hygiene and Tropical Medicine
1
Massachusetts Medical Society
1
McMaster Health Forum
1
McMaster University
1
New England Journal of Medicine
1
NICE Scientific Advice
1
Norwegian Institute of Public Health (NIPH)
1
Paul Ehrlich Institute
1
Semantic Scholar
1
South Africa Medical Reserach Council SAMRC
1
Springer Nature
1
Tegally, H.
1
The Center for Open Science and AfricArXiv
1
The Gamaleya National Center Russia
1
The Lancet
1
The Ottawa Hospital
1
Vaccine Centre at the London School of Hygiene & Tropical Medicine
1
Wolters Kluwer
1
World Health Organization
1
Yale
1
ZB MED Information Centre for Life Sciences
1
ГБУ «НИИОЗММ Д
1
ГБУ «НИИОЗММ ДЗМ»
1
ФГБУ «НМИЦ ФПИ»
1
Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний» Министерства здравоохранения Российской Федерации
1
Publication Years
Category
Countries
12
Pharmacy & Technologies
2
Tests zur Detektion einer Infektion mit SARS-CoV-2 (neuartiges Coronavirus) sowie zum Nachweis von Antikörpern gehören zu den sog. In-vitro-Diagnostika (IVD). Das erstmalige Inverkehrbringen von In-vitro-Diagnostika auf dem deutschen Markt ist nach §§ 25 und 30 Medizinproduktegesetz (MPG) anzeig... more
The key objective is to celebrate, source, and supply innovations across 12 COVID-19 categories (i.e. response areas). The growing list of 800+ featured innovations includes those that are ready to deploy, plus innovations that could be adapted for COVID-19 responses, or inspire new, much-needed sol... more
Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners. The Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19. By... more
A lot of research articles concerning SARS-CoV-2/COVID-19 are published every day. Many of them, so-called pre-prints, are not reviewed in a professional reviewing process at the time of publication. Others are already reviewed and published in well-known journals. Collabovid helps researchers to id... more
FIND is collating an overview of SARS-CoV-2 tests that are commercially available or in development for the diagnosis of COVID-19. We do not guarantee that this is a comprehensive list, since the information below has been submitted voluntarily by test suppliers and is not independently verified. Pl... more
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Almost all organizations recommend masks for the general public. Unfortunately, earlier in the pandemic, many did exactly the opposite – due to limited data but also due to concerns about diminished mask supply for healthcare workers and out of fear that masked individuals might be tempted to igno... more
Every day – Monday, Tuesday, Wednesday, Thursday, Friday, Saturday, Sunday – they present the Top 10 scientific COVID-19 papers of the day. The daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19
A Organização Mundial da Saúde (OMS) convida seus Estados Membros, serviços de saúde e outras entidades para contribuírem com a OMS na vigilância de dados clínicos de casos de pacientes hospitalizados com COVID-19, a fim de melhorar o entendimento global sobre a apresentação clínica dessa... more
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I... more
Методические рекомендации «Правила работы нейрохирургических отделений при подозрении на новую коронавирусную инфекцию COVID-19», Методические рекомендации «Анест... more
Вебинары ФГБУ «НМИЦ ФПИ» Минздрава России для медицинских работников в связи с угрозой распространения нового коронавируса COVID-19
doi: https://doi.org/10.1101/2020.10.28.20221143 This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.